Invasion and metastasis are usually the most dangerous properties of cancers, and in oral SCC recurrence of locoregional disease that is difficult to control accounts for most morbidity and mortality. The invasiveness of oral cancers frequently requires surgical resections that impair important physiological functions, including speech and swallowing. The therapy of oral cancer may be approaching a plateau due to the efficacy and toxicity of the agents used for post-surgical treatment; therefore, addressing the mechanisms of invasion of oral cancers may ultimately lead to the development of novel treatments that attenuate the locoregional spread of these cancers and consequently increase the quality of life and survival times of oral cancer patients. To invade and metastasize cancer cells must penetrate basement membranes, and we have developed methods to assess the risk of squamous cell invasion at early stages of carcinoma development. Using specific anti-peptide monoclonal (MAb) and polyclonal (PAb) antibody reagents we have examined the amounts and distribution of three important basement membrane- degradative enzymes in a series of early (stage I/II) oral cancers at two different locations. Our preliminary results indicate that patients with disease recurrence show histochemical overexpression of these three enzymes in their early stage tumors, consistent with the role of these enzymes in basement membrane invasion. Our hypothesis is that overexpression of degradative enzymes is reflective of the transition from a carcinoma in situ state to an invasive state and that this will be related to recurrence of oral cancer. In the proposed project we will use the anti-peptide PAb and MAb reagents for immunoassays and immunohistochemical studies. We will determine in retrospective and prospective studies if heparinase, urokinase and two metalloproteinases (MMPs), either individually or as a combination, is predictive of tumor recurrence in patients with stage I/II SCCs of the floor of mouth and tongue. Differences between tumors at the same or different primary sites and their ability to recur will be examined to determine if these assays are of prognostic and monitoring value. The results could lead to the development of new approaches for the prognosis and monitoring of oral cancer recurrence.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Specialized Center (P50)
Project #
5P50DE011906-02S2
Application #
2836072
Study Section
Project Start
Project End
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Gonzalez, Hernan E; Gujrati, Manu; Frederick, Mitchell et al. (2003) Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 129:754-9
Jayakumar, Arumugam; Kang, Ya'an; Frederick, Mitchell J et al. (2003) Inhibition of the cysteine proteinases cathepsins K and L by the serpin headpin (SERPINB13): a kinetic analysis. Arch Biochem Biophys 409:367-74
Chun, Kyung-Hee; Benbrook, Doris M; Berlin, K Darrell et al. (2003) The synthetic heteroarotinoid SHetA2 induces apoptosis in squamous carcinoma cells through a receptor-independent and mitochondria-dependent pathway. Cancer Res 63:3826-32
Higuchi, Eisaku; Chandraratna, Roshantha A S; Hong, Waun K et al. (2003) Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotype. Oncogene 22:4627-35
Wang, Heng; Hicks, John; Khanbolooki, Parham et al. (2003) Transgenic mice demonstrate novel promoter regions for tissue-specific expression of the urokinase receptor gene. Am J Pathol 163:453-64
Liu, Yanna; Li, Jun Z; Yuan, Xiao H et al. (2002) An AP-1 binding site mutation in HPV-16 LCR enhances E6/E7 promoter activity in human oral epithelial cells. Virus Genes 24:29-37
Yan, Chunhong; Wang, Heng; Boyd, Douglas D (2002) ATF3 represses 72-kDa type IV collagenase (MMP-2) expression by antagonizing p53-dependent trans-activation of the collagenase promoter. J Biol Chem 277:10804-12
El-Naggar, Adel K; Kim, Hyung W; Clayman, Gary L et al. (2002) Differential expression profiling of head and neck squamous carcinoma: significance in their phenotypic and biological classification. Oncogene 21:8206-19
Shin, M; Yan, C; Boyd, D (2002) An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression. Biochim Biophys Acta 1589:311-6
Hayashi, K; Yokozaki, H; Naka, K et al. (2001) Overexpression of retinoic acid receptor beta induces growth arrest and apoptosis in oral cancer cell lines. Jpn J Cancer Res 92:42-50

Showing the most recent 10 out of 57 publications